RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE:OMI) today reported financial results for the second quarter ended June 30, 2013, including consolidated quarterly revenues of $2.27 billion, increased 3.7% when compared to quarterly revenues of $2.19 billion for the second quarter of 2012. The company's International segment, consisting primarily of Movianto which was acquired in the third quarter of 2012, contributed $123.0 million to second quarter consolidated revenues.

For the second quarter of 2013, net income was $28.9 million, or $0.46 per diluted share, a decline of 4.1% when compared to $30.1 million, or $0.48 per diluted share, for the same period of 2012. For the quarter, adjusted net income (non-GAAP), which excludes pre-tax charges of $0.6 million for acquisition-related and exit & realignment activities in each period, was $29.3 million, or $0.46 per diluted share, compared to $30.5 million, or $0.48 per diluted share, for the same period last year.

"While conditions remain challenging in the U.S. healthcare market, we continue to work on improving day-to-day operations, while making the right investments for our future," said Craig R. Smith, chairman, president & chief executive officer of Owens & Minor. "We continue to receive validation of our approach to the market from our provider and manufacturer partners. While we are very encouraged by the progress we are making in Europe with Movianto, we recognize we still have work to do this year to achieve the goals we have established for our International segment."

Consolidated operating earnings for the second quarter of 2013 were $50.1 million, a decrease of $3.1 million when compared to operating earnings of $53.2 million for the same period in the prior year. Adjusted consolidated operating earnings (non-GAAP) for the second quarter of 2013 were $50.7 million, or 2.24% of revenues, decreased $3.1 million, when compared to adjusted operating earnings of $53.8 million, or 2.46% of revenues, in the same period of 2012. For purposes of comparison, the second quarter 2012 results did not contain results from the company's International segment. On a sequential basis, second quarter adjusted consolidated operating earnings (non-GAAP) as a percentage of revenues improved when compared to both the first quarter of 2013 and the fourth quarter of 2012.

2013 Year-to-Date Results

For the six months ended June 30, 2013, consolidated revenues were $4.54 billion, increased approximately $140 million, or 3.2%, when compared to revenues of $4.40 billion for the first six months of 2012. The International segment contributed $244.0 million to consolidated revenues for the first half of the year. Net income for the first half of 2013 was $55.0 million, or $0.87 per diluted share, a decline of 7.6% when compared to net income of $59.5 million, or $0.94 per diluted share in the same period last year. For the year-to-date period, adjusted net income (non-GAAP), which excludes pre-tax charges of $2.6 million for acquisition-related and exit & realignment activities, was $56.9 million, or $0.90 per diluted share, compared to $59.8 million, or $0.94 per diluted share, in the first six months of 2012.

Consolidated operating earnings for the year-to-date period of 2013 were $97.9 million, or 2.16% of revenues, compared to operating earnings of $105.0 million, or 2.39% of revenues, for the same period of 2012. Adjusted consolidated operating earnings for the year-to-date period were $100.6 million, or 2.21% of revenues, compared to adjusted operating earnings of $105.7 million, or 2.40% of revenues for the same period last year.

Asset Management

The balance of cash and cash equivalents was $208 million at June 30, 2013. For the first half of 2013, the company reported cash provided by operating activities of approximately $180 million, compared to $143 million for the same period last year. The increase in cash from operations was primarily affected by an increase in accounts payable of $191 million, due to an increase in inventories and the timing of payments. Asset management metrics were positive with Domestic segment days sales outstanding (DSO) of 19.3 days as of June 30, 2013, compared favorably to days sales outstanding (DSO) of 19.5 as of June 30, 2012. Domestic inventory turns were 10.3 for the second quarter of 2013, compared to inventory turns of 10.8 for the second quarter of 2012.

Segment Results

Domestic segment revenues for the second quarter of 2013 were $2.14 billion, a decline of 1.9% when compared to the prior year's second quarter revenue of $2.19 billion. The decline in second quarter Domestic segment revenues was primarily due to ongoing market trends, including lower rates of healthcare utilization and reduced government purchases, as well as the company's continued rationalization of smaller, less profitable provider and supplier customers. For the year-to-date period, Domestic segment revenues were $4.3 billion, a decline of 2.4% when compared to revenues of $4.4 billion for the same period last year.

For the second quarter of 2013, Domestic segment operating earnings were $51.2 million, or 2.39% of segment revenues, a decline of approximately $2.5 million when compared to operating earnings of $53.8 million, or 2.46% of segment revenues, in the same period of 2012. During the second quarter of 2013, Domestic segment operating earnings benefitted from settlement of an administrative review by the state of California related to certain municipal sales tax incentives in the net amount of $3.5 million. Domestic segment operating earnings were also positively affected by certain supplier price changes. The majority of the benefits were offset by certain expenses, including higher than expected healthcare costs, litigation expenses, adjustments to benefit accruals, and expenses associated with the transition to a new fleet vendor. For the year-to-date period, Domestic segment operating earnings were $104.2 million, or 2.42% of segment revenues, a decline of $1.5 million when compared to segment operating earnings of $105.7 million in the same period in the prior year.

The International segment contributed revenue of $123.0 million for the second quarter of 2013 and had an operating loss of $0.6 million. The company attributed the sequential improvement in the International segment operating losses to improved capacity utilization and continued attention to cost control measures. For the year-to-date period, the International segment reported $244.0 million in revenues, and an operating loss of $3.6 million, which reduced year-to-date consolidated net income by $0.05 per diluted share.

2013 Outlook

The company reaffirmed its financial guidance for 2013, which remains unchanged since it was provided at the company's Investor Day in November 2012.

For 2013, the company is targeting revenue growth of 2% to 4% and adjusted net income per diluted share of $1.90 to $2.00 for the year, which includes operating results from the Movianto acquisition, but excludes exit and realignment costs, as well as acquisition-related costs.

The 2013 outlook is based on certain assumptions that are subject to the risk factors discussed in the company's filings with the Securities & Exchange Commission.

Highlights

• In the second quarter of 2013, Owens & Minor signed a three-year agreement with MedAssets, effective September 1, 2013, which will remain in effect through August 31, 2016.
• Owens & Minor was honored with a number of awards and distinctions during the second quarter of 2013, including the following:
  • Owens & Minor Distribution has been selected as an Inbound Logistics Top 100 Third-Party Logistics Provider for 2013.
  • Owens & Minor was named U.S. Healthcare Supplier of the Year: Large Organization in the 13^th Annual GHXcellence Awards for leveraging supply chain automation and trading partner collaboration to drive out costs, reduce waste and improve business performance.
  • In June, the Premier healthcare alliance recognized Owens & Minor with the Premier Pinnacle Award, the Premier Polaris Award, and the Premier Supplier Diversity Award.

Investors Conference Call & Supplemental Material

Conference Call: Owens & Minor will conduct a conference call for investors on Tuesday, July 30, 2013, at 8:30 a.m. EDT. The access code for the conference call, international dial-in and replay is #17405913. Participants may access the call at 866-393-1604. The international dial-in number is 224-357-2191. Replay: A replay of the call will be available for one week by dialing 855-859-2056. Webcast: A listen-only webcast of the call, along with supplemental information, will be available on www.owens-minor.com under "Investor Relations."

Information on www.Owens-Minor.com

Owens & Minor uses its website, www.owens-minor.com, as a channel of distribution for material company information, including news releases, investor presentations and financial information. This information is routinely posted and accessible under the Investor Relations section.

Safe Harbor Statement

Except for historical information, the matters discussed in this press release may constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These risk factors are discussed in reports filed by the company with the Securities & Exchange Commission. All of this information is available at www.owens-minor.com. The company assumes no obligation, and expressly disclaims any such obligation, to update or alter information, whether as a result of new information, future events, or otherwise.

Owens & Minor, Inc., (NYSE: OMI) a FORTUNE 500 company headquartered in Richmond, Virginia, is a leading national distributor of name-brand medical and surgical supplies. Owens & Minor also offers global third-party logistics services to pharmaceutical, life-science, and medical-device manufacturers through its European business unit, Movianto, and through its U.S.-based service, OM HealthCare Logistics. With a diverse product and service offering and distribution centers throughout the United States, the company serves hospitals, integrated healthcare systems, alternate site locations, group purchasing organizations, healthcare manufacturers, and the federal government. Owens & Minor also provides technology and consulting programs that improve inventory management and streamline logistics across the entire medical supply chain. For news releases, or for more information about Owens & Minor, visit the company website at www.owens-minor.com.

Owens & Minor, Inc.
Consolidated Statements of Income (unaudited)
(in thousands, except per share data)
		Three Months Ended June 30,
		2013				2012
Net revenue		$	2,266,687			$	2,185,444
Cost of goods sold			1,993,256				1,974,015
Gross margin			273,431				211,429
Selling, general and administrative expenses			212,548				150,288
Acquisition-related and exit and realignment charges			638				617
Depreciation and amortization			12,276				8,515
Other operating income, net			(2,081	)			(1,168	)
Operating earnings			50,050				53,177
Interest expense, net			3,248				3,487
Income before income taxes			46,802				49,690
Income tax provision			17,930				19,577
Net income		$	28,872			$	30,113
Net income per common share:
Basic		$	0.46			$	0.48
Diluted		$	0.46			$	0.48
		Six Months Ended June 30,
		2013				2012
Net revenue		$	4,542,395			$	4,403,326
Cost of goods sold			3,989,913				3,977,569
Gross margin			552,482				425,757
Selling, general and administrative expenses			430,269				305,860
Acquisition-related and exit and realignment charges			2,648				617
Depreciation and amortization			24,905				17,093
Other operating income, net			(3,274	)			(2,862	)
Operating earnings			97,934				105,049
Interest expense, net			6,446				6,909
Income before income taxes			91,488				98,140
Income tax provision			36,518				38,667
Net income		$	54,970			$	59,473
Net income per common share:
Basic		$	0.87			$	0.94
Diluted		$	0.87			$	0.94

Owens & Minor, Inc.
Condensed Consolidated Balance Sheets (unaudited)
(in thousands)
	June 30,			December 31,
	2013			2012
Assets
Current assets
Cash and cash equivalents	$	207,826		$	97,888
Accounts and notes receivable, net		550,642			553,502
Merchandise inventories		794,020			763,756
Other current assets		248,219			213,748
Total current assets		1,800,707			1,628,894
Property and equipment, net		187,512			191,841
Goodwill, net		272,597			274,884
Intangible assets, net		40,050			42,313
Other assets, net		78,628			69,769
Total assets	$	2,379,494		$	2,207,701
Liabilities and equity
Current liabilities
Accounts payable	$	791,004		$	603,137
Accrued payroll and related liabilities		27,106			25,468
Deferred income taxes		46,646			40,758
Other current liabilities		225,428			254,924
Total current liabilities		1,090,184			924,287
Long-term debt, excluding current portion		214,682			215,383
Deferred income taxes		29,501			30,921
Other liabilities		55,306			63,454
Total liabilities		1,389,673			1,234,045
Total equity		989,821			973,656
Total liabilities and equity	$	2,379,494		$	2,207,701

Owens & Minor, Inc.
Consolidated Statements of Cash Flows (unaudited)
(in thousands)
	Six Months Ended June 30,
	2013				2012
Operating activities:
Net income	$	54,970			$	59,473
Adjustments to reconcile net income to cash provided by
operating activities:
Depreciation and amortization		24,905				17,093
Share-based compensation expense		3,449				4,126
Provision for losses on accounts and notes receivable		315				270
Deferred income tax expense (benefit)		5,777				(1,146	)
Changes in operating assets and liabilities:
Accounts and notes receivable		1,789				21,239
Merchandise inventories		(31,176	)			57,519
Accounts payable		191,406				(16,075	)
Net change in other assets and liabilities		(69,462	)			684
Other, net		(2,794	)			(404	)
Cash provided by operating activities		179,179				142,779
Investing activities:
Additions to property and equipment		(16,221	)			(5,460	)
Additions to computer software and intangible assets		(14,826	)			(12,697	)
Proceeds from the sale of property and equipment		68				115
Cash used for investing activities		(30,979	)			(18,042	)
Financing activities:
Cash dividends paid		(30,411	)			(27,956	)
Repurchases of common stock		(8,297	)			(7,500	)
Financing costs paid		-				(1,303	)
Excess tax benefits related to share-based compensation		550				1,160
Proceeds from exercise of stock options		4,195				3,761
Other, net		(5,167	)			(3,900	)
Cash used for financing activities of continuing operations		(39,130	)			(35,738	)
Effect of exchange rate changes on cash and cash equivalents		868				-
Net increase in cash and cash equivalents		109,938				88,999
Cash and cash equivalents at beginning of period		97,888				135,938
Cash and cash equivalents at end of period	$	207,826			$	224,937

Owens & Minor, Inc.
Financial Statistics and GAAP/Non-GAAP Reconciliations (unaudited)
(in thousands, except ratios and per share data)
							Quarter Ended
							6/30/2013			3/31/2013			12/31/2012			9/30/2012			6/30/2012
Consolidated operating results:
Net revenue						$	2,266,687		$	2,275,709		$	2,324,924		$	2,179,895		$	2,185,444
Gross margin						$	273,431		$	279,052		$	270,774		$	228,123		$	211,429
Gross margin as a percent of revenue							12.06%			12.26%			11.65%			10.46%			9.67%
SG&A expenses						$	212,548		$	217,721		$	211,415		$	165,320		$	150,288
SG&A expenses as a percent of revenue							9.38%			9.57%			9.09%			7.58%			6.88%
Operating earnings, as reported (GAAP)						$	50,050		$	47,884		$	45,041		$	46,663		$	53,177
Acquisition-related and exit and realignment charges							638			2,010			1,717			7,831			617
Operating earnings, adjusted (Non-GAAP)						$	50,688		$	49,894		$	46,758		$	54,494		$	53,794
Operating earnings as a percent of revenue, adjusted (Non-GAAP)							2.24%			2.19%			2.01%			2.50%			2.46%
Net income, as reported (GAAP)						$	28,872		$	26,098		$	24,934		$	24,597		$	30,113
Acquisition-related and exit and realignment charges, after-tax							412			1,521			1,237			6,588			375
Net income, adjusted (Non-GAAP)						$	29,284		$	27,619		$	26,171		$	31,185		$	30,488
Net income per diluted common share, as reported (GAAP)						$	0.46		$	0.41		$	0.39		$	0.39		$	0.48
Acquisition-related and exit and realignment charges							-			0.03			0.02			0.10			-
Net income per diluted common share, adjusted (Non-GAAP)						$	0.46		$	0.44		$	0.41		$	0.49		$	0.48
Financing:
Cash and cash equivalents						$	207,826		$	218,563		$	97,888		$	79,667		$	224,937
Total interest-bearing debt						$	216,994		$	216,414		$	217,591		$	216,924		$	213,982
Stock information:
Cash dividends per common share						$	0.24		$	0.24		$	0.22		$	0.22		$	0.22
Stock price at quarter-end						$	33.83		$	32.56		$	28.51		$	29.88		$	30.63
Use of Non-GAAP Measures
This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.'s (the "Company") core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate the Company's performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.
Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on its financial and operating results and in comparing the Company's performance to that of its competitors. However, the non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.
The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.

Owens & Minor, Inc.
Summary Segment Information (unaudited)
(in thousands, except ratios)
					Three Months Ended June 30,
					2013								2012
									% of								% of
									consolidated								consolidated
					Amount				net revenue				Amount				net revenue
	Net revenue:
		Domestic			$	2,143,690			94.57		%		$	2,185,444			100.00	%
		International				122,997			5.43					N/A			N/A
			Consolidated net revenue		$	2,266,687			100.00		%		$	2,185,444			100.00	%
									% of segment								% of segment
	Operating earnings (loss):								net revenue								net revenue
		Domestic			$	51,245			2.39		%		$	53,794			2.46	%
		International				(557	)		(0.45	)	%			N/A			N/A
		Acquisition-related and exit and realignment charges				(638	)		N/A					(617	)		N/A
			Consolidated operating earnings		$	50,050			2.21		%		$	53,177			2.43	%
	Depreciation and amortization:
		Domestic			$	8,887							$	8,515
		International				3,389								N/A
			Consolidated depreciation and amortization		$	12,276							$	8,515
	Capital expenditures: (1)
		Domestic			$	12,872							$	9,781
		International				3,398								N/A
			Consolidated capital expenditures		$	16,270							$	9,781
					Six Months Ended June 30,
					2013								2012
									% of								% of
									consolidated								consolidated
					Amount				net revenue				Amount				net revenue
		Net revenue:
			Domestic		$	4,298,406			94.63		%		$	4,403,326			100.00	%
			International			243,989			5.37					N/A			N/A
				Consolidated net revenue	$	4,542,395			100.00		%		$	4,403,326			100.00	%
									% of segment								% of segment
		Operating earnings (loss):							net revenue								net revenue
			Domestic		$	104,151			2.42		%		$	105,666			2.40	%
			International			(3,569	)		(1.46	)	%			N/A			N/A
			Acquisition-related and exit and realignment charges			(2,648	)		N/A					(617	)		N/A
				Consolidated operating earnings	$	97,934			2.16		%		$	105,049			2.39	%
		Depreciation and amortization:
			Domestic		$	17,969							$	17,093
			International			6,936								N/A
				Consolidated depreciation and amortization	$	24,905							$	17,093
		Capital expenditures: (1)
			Domestic		$	24,474							$	18,157
			International			6,573								N/A
				Consolidated capital expenditures	$	31,047							$	18,157
					June 30, 2013								December 31, 2012
	Total assets:
		Domestic			$	1,757,369							$	1,723,699
		International				414,299								386,114
			Segment assets			2,171,668								2,109,813
			Cash and cash equivalents			207,826								97,888
					$	2,379,494							$	2,207,701
	(1) Represents additions to property and equipment and additions to computer software and separately acquired intangible assets.

Owens & Minor, Inc.
Net Income Per Common Share (unaudited)
(in thousands, except per share data)
						Three Months Ended June 30,									Six Months Ended June 30,
						2013				2012					2013				2012
Numerator:
Net income						$	28,872			$	30,113				$	54,970			$	59,473
Less: income allocated to unvested restricted shares							(156	)			(194	)				(351	)			(421	)
Net income attributable to common shareholders - basic							28,716				29,919					54,619				59,052
Add: undistributed income attributable to unvested restricted shares - basic							64				87					122				176
Less: undistributed income attributable to unvested restricted shares - diluted							(64	)			(87	)				(122	)			(175	)
Net income attributable to common shareholders - diluted						$	28,716			$	29,919				$	54,619			$	59,053
Denominator:
Weighted average shares outstanding — basic							62,707				62,815					62,695				62,825
Dilutive shares - stock options							45				80					51				89
Weighted average shares outstanding — diluted							62,752				62,895					62,746				62,914
Net income per share attributable to common shareholders:
Basic						$	0.46			$	0.48				$	0.87			$	0.94
Diluted						$	0.46			$	0.48				$	0.87			$	0.94

Owens & Minor, Inc.
Trudi Allcott, Director, Investor & Media Relations, 804-723-7555
or
Chuck Graves, Director, Finance & Investor Relations, 804-723-7556

Source: Owens & Minor, Inc.

News Provided by Acquire Media